Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Peras

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Msystems|October 3, 2022
Benchmarking Community-Wide Estimates of Growth Potential from Metagenomes Using Codon Usage StatisticsJ L Weissman, Marie Peras, Tyler P Barnum, et al.
Scientific Reports|July 13, 2023
Topic modeling for multi-omic integration in the human gut microbiome and implications for AutismChristine Tataru, Marie Peras, Erica Rutherford, et al.
The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.
ISME Communications|November 8, 2023
Longitudinal study of stool-associated microbial taxa in sibling pairs with and without autism spectrum disorderChristine Tataru, Austin Martin, Kaitlyn Dunlap, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Msystems|October 3, 2022
Benchmarking Community-Wide Estimates of Growth Potential from Metagenomes Using Codon Usage StatisticsJ L Weissman, Marie Peras, Tyler P Barnum, et al.
Scientific Reports|July 13, 2023
Topic modeling for multi-omic integration in the human gut microbiome and implications for AutismChristine Tataru, Marie Peras, Erica Rutherford, et al.
The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.
ISME Communications|November 8, 2023
Longitudinal study of stool-associated microbial taxa in sibling pairs with and without autism spectrum disorderChristine Tataru, Austin Martin, Kaitlyn Dunlap, et al.
Pageof 1